総説

The role of reactive oxidative species in insulin resistance-associated cardiovascular disease

Noman Ali, Mark T Kearney & Richard M Cubbon

• 抽象的な

医薬品の評価

Canagliflozin for the treatment of adults with Type 2 diabetes

Gary Meininger, William Canovatchel, David Polidori & Norm Rosenthal

• 抽象的な

総説

Role of sodium status in the clinical management of diabetic nephropathy: interaction with RAAS-blockade efficacy

Martin H de Borst & Gerjan Navis

• 抽象的な

視点記事

Patients nonadherence and doctors clinical inertia: two faces of medical irrationality

Gerard Reach

• 抽象的な

総説

Childhood-onset Type 1 diabetes and cardiovascular disease

Reena Perchard & Rakesh Amin

• 抽象的な